These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 18257534)

  • 1. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of natural products upon modern drug discovery.
    Ganesan A
    Curr Opin Chem Biol; 2008 Jun; 12(3):306-17. PubMed ID: 18423384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
    Genis D; Kirpichenok M; Kombarov R
    Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular properties that influence oral drug-like behavior.
    Lajiness MS; Vieth M; Erickson J
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical view of 'druggability'.
    Keller TH; Pichota A; Yin Z
    Curr Opin Chem Biol; 2006 Aug; 10(4):357-61. PubMed ID: 16814592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational approaches to natural-product-based drug design.
    Haustedt LO; Mang C; Siems K; Schiewe H
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles, implementation, and application of biology-oriented synthesis (BIOS).
    Wilk W; Zimmermann TJ; Kaiser M; Waldmann H
    Biol Chem; 2010 May; 391(5):491-7. PubMed ID: 20030592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M; Schmidt JM
    J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
    Kutchukian PS; Lou D; Shakhnovich EI
    J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural product-likeness score and its application for prioritization of compound libraries.
    Ertl P; Roggo S; Schuffenhauer A
    J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of screening libraries based on the muurolane natural product scaffold.
    Barnes EC; Choomuenwai V; Andrews KT; Quinn RJ; Davis RA
    Org Biomol Chem; 2012 May; 10(20):4015-23. PubMed ID: 22422350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment library design, synthesis and expansion: nurturing a synthesis and training platform.
    Ray PC; Kiczun M; Huggett M; Lim A; Prati F; Gilbert IH; Wyatt PG
    Drug Discov Today; 2017 Jan; 22(1):43-56. PubMed ID: 27793744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity-based protein profiling for natural product target discovery.
    Krysiak J; Breinbauer R
    Top Curr Chem; 2012; 324():43-84. PubMed ID: 22025071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-like properties: guiding principles for the design of natural product libraries.
    Camp D; Davis RA; Campitelli M; Ebdon J; Quinn RJ
    J Nat Prod; 2012 Jan; 75(1):72-81. PubMed ID: 22204643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.